Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Grant entities : Gilead sciences, inc. save search
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
Published: 2023-07-28 (Crawled : 22:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: -0.12%
H: 1.18%
C: 0.58%
hepatitis health world global grant program
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.
Published: 2023-07-20 (Crawled : 21:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: 0.76%
H: 1.53%
C: 0.48%
hepatitis grant program funding
Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities
Published: 2023-03-22 (Crawled : 18:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: -0.05%
H: 0.35%
C: -1.63%
sciences grant hiv funding
Second Genome Granted U.S. Patent for Proteins for the Treatment or Prevention of Epithelial Barrier Function Disorders
Published: 2021-12-20 (Crawled : 13:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: -0.3%
H: 0.72%
C: 0.65%
treatment order patent granted grant
Susan G. Komen® Announces $1.5 Million in Grants for Metastatic Breast Cancer Research
Published: 2021-10-13 (Crawled : 13:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: 0.31%
H: 0.56%
C: 0.07%
cancer research breast cancer granted grant metastatic breast cancer
FDA Grants Marketing Authorization to Siemens Healthineers ELF Test for NASH Prognostic Assessment
Published: 2021-08-24 (Crawled : 18:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: 0.11%
H: 0.08%
C: -0.52%
fda test nash authorized granted grant
Everest Medicines Announces China NMPA Has Granted Priority Review for Sacituzumab Govitecan-hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-05-20 (Crawled : 11:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: 0.23%
H: 1.92%
C: 1.0%
china cancer breast cancer granted grant
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
Published: 2021-04-13 (Crawled : 22:00) - biospace.com/
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: -0.32%
H: 1.19%
C: 0.68%
treatment fda cancer approval granted grant
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.